Reply to Nishimura, "Questions regarding mortality and infection source in deep-seated infections". [PDF]
Slain N, Kunz Coyne AJ.
europepmc +1 more source
<i>In vitro</i> activity of cefepime/zidebactam against <i>Klebsiella pneumoniae</i> carrying <i>bla</i> <sub>KPC</sub> variants conferring resistance to ceftazidime/avibactam. [PDF]
Tascini C +3 more
europepmc +1 more source
Case records of the Massachusetts General Hospital. Case 1-2014. A 32-year-old man with loss of vision and a rash [PDF]
Blanchard, Melvin S +2 more
core +2 more sources
Population Pharmacokinetic Modeling and Target Attainment of Cefepime in Critically Ill Pediatric Patients. [PDF]
Rolsma SL +10 more
europepmc +1 more source
Activity of cefepime/enmetazobactam against highly multidrug-resistant bacterial isolates recovered from war-associated wounds in Ukraine. [PDF]
Boral J +7 more
europepmc +1 more source
Mixed hepatocellular-cholestatic liver injury from cefepime: A case report. [PDF]
Garcia R, English K.
europepmc +1 more source
Comparison of Patient Outcomes in a Pharmacist-Led Parenteral Antimicrobial Therapy Program [PDF]
Howe, Zachary W. +2 more
core +1 more source
Current progress in antibacterial agents for carbapenem-resistant enterobacterales. [PDF]
Xu W +10 more
europepmc +1 more source
Pharmacodynamic studies of taniborbactam (VNRX-5133) combined with cefepime against β-lactamase-producing Gram-negative bacteria in a neutropenic murine thigh infection model. [PDF]
Georgiou PC +6 more
europepmc +1 more source
Cefepime neurotoxicity in elderly patient with renal impairment: a case report. [PDF]
Furqan M +4 more
europepmc +1 more source

